Shanghai Haixin Group (600851) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

600851 Shanghai Haixin Group

Watchlist

6.06
+0.10+1.68%

Market Closed Dec 27 15:00 CST

7.31BMarket Cap40.95P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Earnings Not Telling The Story For Shanghai Haixin Group Co., Ltd. (SHSE:600851) After Shares Rise 26%
Simply Wall StDec 14 19:26 ET
Shanghai Haixin Group Co., Ltd.'s (SHSE:600851) Biggest Owners Are Retail Investors Who Got Richer After Stock Soared 13% Last Week
Simply Wall StDec 12 22:06 ET
Shanghai Haixin Group (600851.SH): The operation scope of Shanghai Haixin Biotechnology Co., Ltd. does not involve AI medicine.
Gelonghui November 22nd | Shanghai haixin group (600851.SH) stated on the investor interaction platform that shanghai haixin biotechnology co., ltd. does not involve AI medicine in its operation scope.
Gelonghui FinanceNov 22 04:13 ET
Earnings Are Growing at Shanghai Haixin Group (SHSE:600851) but Shareholders Still Don't Like Its Prospects
Simply Wall StNov 14 17:01 ET
Shanghai Haixin Group Co., Ltd. Third Quarter Report 2024
SZSIOct 29 12:00 ET · Announcements
Earnings Not Telling The Story For Shanghai Haixin Group Co., Ltd. (SHSE:600851) After Shares Rise 42%
Simply Wall StOct 8 18:26 ET

Comments

Moomoo AI

Jan 29 23:58

Despite Shanghai Haixin Group's recent poor growth, it trades at a higher P/E than the market. Investors hope for a business turnaround, but unless medium-term conditions improve, the high P/E ratio may decrease, potentially leading to a share price decline.

Shanghai Haixin Group Co., Ltd.'s (SHSE:600851) Share Price Not Quite Adding Up

Moomoo AI

Oct 21, 2023 20:54

Shanghai Haixin Group's modest earnings growth and efficient profit usage may not offset its weak ROE, potentially impacting investor returns. Investors should also consider its risk profile before making decisions.